LUDG.US Ludwig Enterprises Inc

Healthcare Health Care Equipment & Supplies USA Stocks
0.0040 USD
Close of Nov 15, 2026
0.0030 0.0750
Market cap
USD 669K
P/E
0.4x
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is LUDG.US undervalued?

Graham number

The Graham number of Ludwig Enterprises Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ludwig Enterprises Inc fundamental analysis

No fundamental analysis for Ludwig Enterprises Inc yet.

Ludwig Enterprises Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ludwig Enterprises Inc

Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States. The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification. It offers mRNA-based screening to provide early insights of potential health risks. The company develops Revealia Breast test, a non-inva…

Full company profile